Antifungal effect of Satureja khuzestanica Jamzad essential oil on oral candidiasis in immunosuppressed rats

• Autorzy: Najibzadeh T. , Yadegary M.H.
• Języki publikacji: EN

Abstrakty

EN

The antimicrobial, antibacterial, antioxidant, antihyperlipidaemic, antidiabetic, anti-inflammatory and analgesic effects of Satureja khuzestanica (Lamiaceae) have been investigated in numerous studies. The antifungal effects of S. khuzestanica essential oil (SKJO) in immunosuppressed rats suffering from oral candidiasis were investigated. A fungal suspension with a density of 3×108 CFU/ml was taken from the isolate of a case with acute vaginitis. In order to achieve a medicinal formulation, accurate twice the minimum inhibitory concentration (MIC) of SKJO and 10 times MIC of nystatin was used with 0.8% agar as a base material. In this study, 35 rats divided into 5 groups each of 7 were used. The assessment of level of infection and specification of the effects of treatment were performed using microbiological and histopathological methods as well as clinical examinations. Our results show that carvacrol is the main compound of SKJ essential oil. Lesions completely disappeared in both treatment groups (SKJO and nystatin) after 8 days of treatment. Furthermore, in groups treated with SKJO and nystatin, the quantities of mean logarithm of colony forming unit (CFU) were 85.62% and 90.62%, respectively, in comparison with placebo group. Also, histopathological properties suggested no infection in groups who had clean and normal dorsal tongue mucosa. Using SKJO with twice accuracy it was concluded that MIC in immunosuppressed rats was quite successful in a time of a week and equal with that of a nystatin treatment with an accuracy of 10 times the MIC.

Słowa kluczowe

EN

aromatic plant; Satureja khuzestanica; antifungal effect; essential oil; oral candidiasis; rat; immunosuppression; candidiasis

• Wydawca: -
• Czasopismo: Herba Polonica
• Rocznik: 2018
• Tom: 64
• Numer: 3
• Opis fizyczny: p.38-49,fig.,ref.

Twórcy

autor

Najibzadeh T.

• Department of Mycology, Faculty of Medicine, Tarbiat Modares University School of Medical Sciences, Tehran, Iran

autor

Yadegary M.H.

• Department of Mycology, Faculty of Medicine, Tarbiat Modares University School of Medical Sciences, Tehran, Iran

Bibliografia

• 1. Wingard JR. Importance of candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis Jan 1995; 20 (1):115-25. doi: http://dx.doi.org/10.1093/clinids/20.1.115
• 2. Calderon RA, Fonzi WA. Virulence factor of Candida albicans. Trends Microbiol 2001; 327-335. doi: http:// dx.doi.org/10.1016/S0966-842X(01)02094-7
• 3. Singh N. Trends in the epidemiology of opportunistic fungal infections: predisposing factors of antimicrobial use practices (Review article). Clin Infect Dis 2001; 33:1692-1696. doi: http:// dx.doi.org/10.1086/323895 48 T. Najibzadeh, MH. Yadegarya
• 4. Samaranayake LP. Oral mycoses in HIV infection. Oral Med Oral Pathol 1992; 73: 171- 180. doi: http:// dx.doi.org/10.1016/0030- 4220(92)90191-R
• 5. Dignani MC, Solomkin JS, Anaissie EJ, Candida. In: Anaissie EJ, McGinnis MR, Pfaller MA. Clinical Mycology. Churchill Livingstone 2003:195-239.
• 6. Samaranayake LP, Lamey PJ. Oral candidosis: 1. Clinicopathological aspects. Dent Update 1988; 15:227-228, 230-231.
• 7. Mac Phail LM, Green Span D, Dodd CL, Heinic GS, Beck C, Ekoku E. Association of fungal species with oral candidiasis in HIV infection. J Dent Res 1993; 72:353.
• 8. Samaranayake YH, Samaranayake LP. Experimental oral candidiasis in animal models. J Clin Microbiol 2001; 14: 398-429. doi: http://dx.doi. org/10.1128/CMR.14.2.398-429.2001
• 9. Ellepolla A N B, Samaranayake LP. Oral candidal infections and antimycoties. Crit Rev Oral Biol Med 2000; 11:172-198.
• 10. Kauffman CA, Carver PL. Antifungal agents in the 1990s. Current status and future developments. Drugs 1997; 53:539-549. doi: http:// dx.doi.org/10.2165/00003495-199753040- 00001
• 11. Ahmad S, Khan Z, Mustafa AS, Khan ZU. Seminested PCR for diagnosis of candidemia: comparison with culture, antigen detection, and biochemical methods for species identification. J Clin Microbiol 2002; 40(7):2483-2489. doi: http://dx.doi.org/10.1128/JCM.40.7.2483- 2489.2002
• 12. Ghasemi Dehkordi N. Iranian Herbal Pharmacopoeia (IHP). Min Health Pub 2002; 2:749-753.
• 13. Abdollahi M, Salehnia A, Mortazavi SH, Ebrahimi M, Shafiee A, Fouladian F, et al. Antioxidant, antidiabetic, antihyperlipidemic, reproduction stimulatory properties and safety of essential oil of Satureja khuzestanica in rat in vivo: a toxicopharmacological study. Med Sci Monit 2003; 9: BR331-335.
• 14. Amanlou M, Fazeli MR, Arvin A, Amin HG, Farsam H. Antimicrobial activity of crude methanolic extract of Satureja khuzestanica. Fitoterapia 2004; 75:768-770.
• 15. Radpour M. Identification and structure of native and cultivated Satureja khuzestanica using GC-MS. Professional Doctorate Thesis, Faculty of Pharmacy, Teheran University of Medical Sciences, Thesis No. 4261, 2002.
• 16. National committee for clinical laboratories standard. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. National committee clinical laboratories standard, 1997.
• 17. Evans EGV, Richardson MD. Medical mycology. A practical approach. Oxford 1989.
• 18. Chami N, Chami F, Bennis S, Trouillas J, Remmal A. Antifungal treatment with carvacrol and eugenol of oral candidiasis in immunosuppressed rats. Braz Infect Dis 2004; 8:217-26. doi:http://dx.doi.org/ S1413-86702004000300005
• 19. Martinez A, Ferrer S, Santos I, Jimenez E, Sparrowe J, Regadera J, et al. Antifungal activities of two new Azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats. Antimicrob Agents Chemother 2001; 45:3304-3309. doi: http://dx.doi.org/10.1128/ AAC.45.12.3304-3309.2001
• 20. Martinez A, Regardera J, Jimenez E, Santos I, Gargallo-Viola D. Antifungal efficacy of GM237354, a sordarin derivative, in experimental oral candidiasis in immunosuppressed rats. Antimicrob Agents Chemother 2001; 5:1008-1013. doi: http://dx.doi.org/10.1128/ AAC.45.4.1008-1013.2001
• 21. Üner A, Nceboz T, Uysalci M, Dagci H. Immune deficiency and cryptosporidiosis in rats. Turk J Vet Anim Sci 2003; 27:1187-1191.
• 22. Sepahvand A. Effects of antifungal Satureja huzestanika using in vitro in Lorestan province. MS, Faculty of Health and Institute for Health Research, Tehran University of Medical Sciences, Thesis No. 5348, 2004.
• 23. Ultee A, Kets EPW, Smid ET. Mechanism of action of carvacrol on the food borne pathogen The antifungal effect of Satureja khuzestanica Jamzad essential oil on oral candidiasis in immunosuppressed rats Bacillus cereus. Appl Environ Microbiol 1999; 65:4606-4610.
• 24. Amin GH, Salehi MH, Zahedi M, Khanavi M, amadi N. Essential oil composition and antimicrobial activity of Oliveria decumbens. Fitoterapia 2005; 76:704-707.
• 25. Braga PC, Alfieri M, Culici M, Dal Sasso M. Inhibitory activity of thymol against the formation and viability of Candida albicans hyphae. Mycoses 2007; 50:502-506. doi: http:// dx.doi. org/10.1111/j.1439-0507.2007.01412.x
• 26. Manohar V, Ingram C, Gray J, Tlpur NA, Echarad BW, Bagchi D et al. Antifungal activities of origanum oil against Candida albicans. Mol Cell Biochem 2001; 228:111-117. doi: http://dx.doi. org/10.1023/A:1013311632207
• 27. Cosentino S, Tuberose CIG, Pishao B, Satta M, Mascia V, Arzedi E, Palmas F. In vitro antimicrobial activity and chemical composition of Thymus sardinian essential oils. Lett Appl Microbiol 1999; 29:130-135. doi: http://dx.doi. org/10.1046/j.1472-765X.1999.00605.x
• 28. Grainger W, Presteril E, Schneeweiss B, Teleky B, Georgopoulos A. Treatment of Candida albicans fungamia with fluconazole. J Infect 1993; 26:133-146.
• 29. Russell C, Jones J. Effects of oral inoculation of Candida albicans in tetracycline-treated rats. J Med Microbiol 1973; 6:275-279.
• 30. Kimura LH, Pearsall NN. Relationship between germination of Candida albicans and increased adherence to buccal epithelial cells. Infect Immun 1980; 28:464-468.
• 31. Martinez MV, Craig GT, Lamb DJ. An investigation of the role of true hypha production in the pathogenesis of experimental oral candidiosis. Sabouraudia 1984; 22:471-476.
• 32. Odds FC. Candida and candidiasis. Leicester 1979.
• 33. Winner HI, Hurley R. Candida albicans. London 1964.
• 34. O’Grady JF, Reade PC. Role of thermal trauma in experimental oral mucosal candida infection in rat. J Oral Pathol Med 1993; 22: 132-137. doi: http://dx.doi.org/10.1111/j.1600-0714.1993.tb01044.x
• 35. Arvin A. Phytochemistry, typography and study of effects of antimicrobial and antifungal Satureja khuzestanika. Indigenous and cultivated. Professional Doctorate Thesis, Faculty of Pharmacy, Tehran University of Medical Sciences, ThesisNo. 4360, 2002-82.

Identyfikatory

DOI

10.2478/hepo-2018-0017